Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 45, Issue 8 (Aug 2007)

Issues

A plea for intra-laboratory reference limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory databases demonstrated by catalytic activity concentrations of enzymes

Farhad Arzideh / Werner Wosniok / Eberhard Gurr / Wilhelm Hinsch / Gerhard Schumann / Nicodemo Weinstock / Rainer Haeckel

Abstract

Background: The current recommendations for establishing intra-laboratory reference limits (RLs) cannot be fulfilled by most laboratories because of the expense involved. In the current study, a bimodal method was developed to derive RLs from data stored in a laboratory information system without any assumption concerning the distribution of the diseased subgroup.

Methods: A smoothed kernel density function (Dmix) was estimated for the distribution of combined data for non-diseased and diseased adult subjects. It was assumed that the “central” part of the distribution represents the non-diseased population, which was defined and used to estimate a Gaussian distribution of either the original values or Box-Cox transformed data. This normal distribution was now considered the distribution of the non-diseased subgroup (Dnd). Percentiles were calculated to obtain retrospective RLs. The density function of the diseased subgroup (Dd) was calculated by subtracting the non-diseased density function from Dmix (Dd=Dmix–Dnd). The intersection point of the Dnd and Dd curves identified the RL with the highest diagnostic efficiency.

Results: The model was applied to catalytic activity concentrations of several enzymes with data from different laboratories. The RLs obtained were similar to recently published consensus values. Differences between laboratories were small but significant. Gender stratification was necessary for alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutymaltransferse (γ-GT), not significant for lipase and amylase and inconsistent among the laboratories for alkaline phosphatase (AP) and lactate dehydrogenase (LDH). Age stratification was only tested for two groups (18–49 and ≥50 years) and was significant for AST (females only), γ-GT and lipase, not significant for amylase and inconsistent for AP, LDH and ALT. For γ-GT, further stratification for age in decades was necessary for males. Creatine kinase MB (CK-MB) values were not stratified owing to the low number of data available.

Conclusions: Retrospective RLs derived from intra-laboratory data pools for the catalytic activity concentration of enzymes using a modified procedure plausibly agreed with published consensus values. However, most RLs varied significantly among laboratories, thus supporting the “old” plea for intra-laboratory RLs.

Clin Chem Lab Med 2007;45:1043–57.

Keywords: decision limits; enzyme catalytic activity concentrations; reference limits

About the article

Corresponding author: Prof. Dr. Rainer Haeckel, Diagnostic Center Wagner Stibbe, Werner-von-Siemens Str. 10, 37077 Göttingen, Germany Phone: +49-421-273446,


Received: 2007-01-02

Accepted: 2007-04-07

Published in Print: 2007-08-01


Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: https://doi.org/10.1515/CCLM.2007.250.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Georg Hoffmann, Ralf Lichtinghagen, and Werner Wosniok
LaboratoriumsMedizin, 2016, Volume 39, Number 6
[2]
Georg Hoffmann, Ralf Lichtinghagen, and Werner Wosniok
LaboratoriumsMedizin, 2015, Volume 39, Number 6
[3]
Hale Aral, Murat Usta, Ahmet M. Cilingirturk, Berrin B. Inal, Pinar T. Bilgi, and Guvenc Guvenen
Scandinavian Journal of Clinical and Laboratory Investigation, 2011, Volume 71, Number 8, Page 647
[4]
Farhad Arzideh, Werner Wosniok, and Rainer Haeckel
Clinica Chimica Acta, 2010, Volume 411, Number 3-4, Page 215
[6]
Farhad Arzideh, Werner Wosniok, and Rainer Haeckel
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 4
[10]
Eberhard Gurr, Friedrich Krönig, Anja Golbeck, and Farhad Arzideh
LaboratoriumsMedizin, 2009, Volume 33, Number 2, Page -
[11]
Farhad Arzideh, Gunnar Brandhorst, Eberhard Gurr, Wilhelm Hinsch, Torsten Hoff, Lennart Roggenbuck, Gregor Rothe, Gerhard Schumann, Bernd Wolters, Werner Wosniok, and Rainer Haeckel
LaboratoriumsMedizin, 2009, Volume 33, Number 2, Page 52
[12]
Joseph Henny
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 8
[13]
Rainer Haeckel and Werner Wosniok
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 10
[14]
Rainer Haeckel, Werner Wosniok, and Farhad Arzideh
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 4
[15]
Rainer Haeckel, Werner Wosniok, and Farhad Arzideh
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 8
[16]
Annemarie M. C. Simonis-Bik, Elisabeth M. W. Eekhoff, Michaela Diamant, Dorret I. Boomsma, Rob J. Heine, Jacqueline M. Dekker, Gonneke Willemsen, Marieke van Leeuwen, and Eco J. C. de Geus
Twin Research and Human Genetics, 2008, Volume 11, Number 06, Page 597

Comments (0)

Please log in or register to comment.
Log in